Andrea Párniczky 1 , László Czakó 2 , Zsolt Dubravcsik 3 , Gyula Farkas 4 , Péter Hegyi 5 , István Hritz 6 , Dezső Kelemen 7 , Zita Morvay 8 , Attila Oláh 9 , Ákos Pap 10 , Miklós Sahin-Tóth 11 , Flóra Szabó 12 , Zsolt Szentkereszti 13 , Richárd Szmola 14 , Tamás Takács 2 , László Tiszlavicz 15 , Gábor Veres 16 , Ákos Szücs 17 , Natália Lásztity 1
Feb 22 2015
Pediatric pancreatitis is a rare disease with variable etiology. In the past 10-15 years the incidence of pediatric pancreatitis has been increased. The management of pediatric pancreatitis requires up-to-date and evidence based management guidelines. The Hungarian Pancreatic Study Group proposed to prepare an evidence based guideline based on the available international guidelines and evidences. The preparatory and consultation task force appointed by the Hungarian Pancreatic Study Group translated and complemented and/or modified the international guidelines if it was necessary. In 8 clinical topics (diagnosis; etiology; prognosis; imaging; therapy; biliary tract management; complications; chronic pancreatitis) 50 relevant questions were defined. Evidence was classified according to the UpToDate(®) grading system. The draft of the guidelines was presented and discussed at the consensus meeting on September 12, 2014. All clinical statements were accepted with total (more than 95%) agreement. The present Hungarian Pancreatic Study Group guideline is the first evidence based pediatric pancreatitis guideline in Hungary. The present guideline is the first evidence-based pancreatic cancer guideline in Hungary that provides a solid ground for teaching purposes, offers quick reference for daily patient care in pediatric pancreatitis and guides financing options. The authors strongly believe that these guidelines will become a standard reference for pancreatic cancer treatment in Hungary.